Search
Protocol No.: COG-AALL1621
- Title
- AALL1621 - A Phase 2 Study of Inotuzumab Ozogamicin (NSC# 772518, IND# 133494) in Children and Young Adults with Relapsed or Refractory CD22+ B-Acute Lymphoblastic Leukemia (B-ALL)
- Principal Investigator
- Meyer, Ashley
- Phase
- II
- Age Group
- Both
- Applicable Disease Site
- Leukemia
- Participating Institution
- Mary Babb Randolph Cancer Center
- Contacts
- Carla Corbin, RN, BSN
- Nurse Clinician
- Phone: +1 304-293-1217
- Email: ccorbin@hsc.wvu.edu
- April Shay, MSN, PNP-BC
- Nurse Practitioner
- Phone: +1 304-293-1217
- Email: ashay@hsc.wvu.edu
- Christy Glass, MSN
- APRN
- Phone: +1 304-598-4835
- Email: christy.glass@hsc.wvu.edu
- Ashley Kitzmiller, RN
- Nurse Coordinator
- Phone: +1 304-293-1217
- Email: ashley.tomasello@wvumedicine.org
- Sara Gamal, BS
- Coordinator National Quality Programs
- Phone: +1 304-974-5000
- Email: sara.gamal@wvumedicine.org